Your browser doesn't support javascript.
loading
Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
Rishi R Goel; Mark M Painter; Kendall A Lundgreen; Sokratis A Apostolidis; Amy E Baxter; Josephine R Giles; Divij Mathew; Ajinkya Pattekar; Arnold Reynaldi; David S Khoury; Sigrid Gouma; Philip Hicks; Sarah Dysinger; Amanda Hicks; Harsh Sharma; Sarah Herring; Scott Korte; Wumesh KC; Derek A Oldridge; Rachel I Erickson; Madison E Weirick; Christopher M McAllister; Moses Awofolaju; Nicole Tanenbaum; Jeanette Dougherty; Sherea Long; Jacob T Hamilton; Maura McLaughlin; Justine C Williams; Sharon Adamski; Oliva Kuthuru; Elizabeth M Drapeau; Miles P Davenport; Scott E Hensley; Paul Bates; Allison R Greenplate; E. John Wherry.
Afiliação
  • Rishi R Goel; University of Pennsylvania
  • Mark M Painter; University of Pennsylvania
  • Kendall A Lundgreen; University of Pennsylvania
  • Sokratis A Apostolidis; University of Pennsylvania
  • Amy E Baxter; University of Pennsylvania
  • Josephine R Giles; University of Pennsylvania
  • Divij Mathew; University of Pennsylvania
  • Ajinkya Pattekar; University of Pennsylvania
  • Arnold Reynaldi; University of New South Wales
  • David S Khoury; University of New South Wales
  • Sigrid Gouma; University of Pennsylvania
  • Philip Hicks; University of Pennsylvania
  • Sarah Dysinger; University of Pennsylvania
  • Amanda Hicks; University of Pennsylvania
  • Harsh Sharma; University of Pennsylvania
  • Sarah Herring; University of Pennsylvania
  • Scott Korte; University of Pennsylvania
  • Wumesh KC; University of Pennsylvania
  • Derek A Oldridge; University of Pennsylvania
  • Rachel I Erickson; University of Pennsylvania
  • Madison E Weirick; University of Pennsylvania
  • Christopher M McAllister; University of Pennsylvania
  • Moses Awofolaju; University of Pennsylvania
  • Nicole Tanenbaum; University of Pennsylvania
  • Jeanette Dougherty; University of Pennsylvania
  • Sherea Long; University of Pennsylvania
  • Jacob T Hamilton; University of Pennsylvania
  • Maura McLaughlin; University of Pennsylvania
  • Justine C Williams; University of Pennsylvania
  • Sharon Adamski; University of Pennsylvania
  • Oliva Kuthuru; University of Pennsylvania
  • Elizabeth M Drapeau; University of Pennsylvania
  • Miles P Davenport; University of New South Wales
  • Scott E Hensley; University of Pennsylvania
  • Paul Bates; University of Pennsylvania
  • Allison R Greenplate; University of Pennsylvania
  • E. John Wherry; University of Pennsylvania
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-481163
ABSTRACT
Despite a clear role in protective immunity, the durability and quality of antibody and memory B cell responses induced by mRNA vaccination, particularly by a 3rd dose of vaccine, remains unclear. Here, we examined antibody and memory B cell responses in a cohort of individuals sampled longitudinally for [~]9-10 months after the primary 2-dose mRNA vaccine series, as well as for [~]3 months after a 3rd mRNA vaccine dose. Notably, antibody decay slowed significantly between 6- and 9-months post-primary vaccination, essentially stabilizing at the time of the 3rd dose. Antibody quality also continued to improve for at least 9 months after primary 2-dose vaccination. Spike- and RBD-specific memory B cells were stable through 9 months post-vaccination with no evidence of decline over time, and [~]40-50% of RBD-specific memory B cells were capable of simultaneously recognizing the Alpha, Beta, Delta, and Omicron variants. Omicron-binding memory B cells induced by the first 2 doses of mRNA vaccine were boosted significantly by a 3rd dose and the magnitude of this boosting was similar to memory B cells specific for other variants. Pre-3rd dose memory B cell frequencies correlated with the increase in neutralizing antibody titers after the 3rd dose. In contrast, pre-3rd dose antibody titers inversely correlated with the fold-change of antibody boosting, suggesting that high levels of circulating antibodies may limit reactivation of immunological memory and constrain further antibody boosting by mRNA vaccines. These data provide a deeper understanding of how the quantity and quality of antibody and memory B cell responses change over time and number of antigen exposures. These data also provide insight into potential immune dynamics following recall responses to additional vaccine doses or post-vaccination infections. Graphical Summary O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=123 SRC="FIGDIR/small/481163v1_ufig1.gif" ALT="Figure 1"> View larger version (20K) org.highwire.dtl.DTLVardef@123d2d9org.highwire.dtl.DTLVardef@e7db82org.highwire.dtl.DTLVardef@1fc73deorg.highwire.dtl.DTLVardef@11b21f9_HPS_FORMAT_FIGEXP M_FIG C_FIG
Licença
cc_by_nd
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Cohort_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Tipo de estudo: Cohort_studies / Estudo observacional / Estudo prognóstico Idioma: Inglês Ano de publicação: 2022 Tipo de documento: Preprint
...